Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantationJohn R. Wingard, Kieren A. Marr, Shelly L. Carter et al.|Blood|2010Cited by 477
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and RecommendationsSergio Giralt, Steven M. Devine, Chitra Hosing et al.|Biology of Blood and Marrow Transplantation|2013Cited by 402
Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow TransplantationHien K. Duong, Paul A. Carpenter, Bipin N. Savani et al.|Biology of Blood and Marrow Transplantation|2014Cited by 210
Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients.John R. Wingard, Kieren A. Marr, Shelly L. Carter et al.|Blood|2007Cited by 91
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patientsLeylah Drusbosky, Christopher R. Cogle, Neeraj Kumar Singh et al.|Blood Advances|2019Cited by 15